<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://adc.bmj.com">
<title>Archives of Disease in Childhood current issue</title>
<link>http://adc.bmj.com</link>
<description>Archives of Disease in Childhood RSS feed -- current issue</description>
<prism:eIssn>1468-2044</prism:eIssn>
<prism:coverDisplayDate>Jul  1 2013 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Archives of Disease in Childhood</prism:publicationName>
<prism:issn>0003-9888</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/i?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/481?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/483?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/485?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/490?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/495?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/497?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/503?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/510?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/514?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/515?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/520?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/521?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/526?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/533?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/537?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/538?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/544?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/545?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/548?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/552?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/556?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/558?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/558-a?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/561?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/564?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/565?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/565-a?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/567?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/568?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/7/570?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://hwmaint.adc.bmj.com/misc/home/ADC_95x60.gif" />
</channel>
<image rdf:about="http://hwmaint.adc.bmj.com/misc/home/ADC_95x60.gif">
<title>Archives of Disease in Childhood</title>
<url>http://hwmaint.adc.bmj.com/misc/home/ADC_95x60.gif</url>
<link>http://adc.bmj.com</link>
</image>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/i?rss=1">
<title><![CDATA[Highlights from this issue]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/i?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Strategies to control pertussis in infants</st> <p>The UK is in the midst of a pertussis outbreak with the highest morbidity and mortality being in young unimmunised infants. Over the last 10&ndash;15&nbsp;years high vaccine coverage, the accelerated infant schedule and the inclusion of pertussis in the preschool booster have contributed to a major overall decline in incidence. However pertussis remains the most common cause of hospitalisation and death from a disease potentially preventable through the current UK immunisation programme, and continues to display 3&ndash;4 yearly peaks in activity affecting infants, adolescents and adults. Gayatri Amirthalingam reviews the evidence base for and potential strategies to control pertussis in infants. The challenge is to improve individual immunity and thereby reduce infection and transmission. The potential strategies include the introduction of an adolescent pertussis booster to compensate for waning immunity as has been introduced in USA, Australia and France, immunisation of close...]]></description>
<dc:creator><![CDATA[Beattie, R. M.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-304520</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-304520</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Highlights from this issue]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Atoms</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>i</prism:startingPage>
<prism:endingPage>i</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/481?rss=1">
<title><![CDATA[Health and social care: will they work together for children now?]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/481?rss=1</link>
<description><![CDATA[ <p>The National Health Service (NHS) is embarking on significant changes. The new Health and Social Care Act comes into force on 1 April 2013 alongside increasing demographic challenges and capacity pressures. While costs are set to soar, finances are increasingly constrained so that the effective delivery of integrated out-of-hospital care coordinated around the needs of the child and family is vital. The case report<cross-ref type="bib" refid="R1">1</cross-ref> illustrates how families&rsquo; lives are turned upside down when sustaining complex care at home. Adverse medical outcomes may partly reflect the difficulties connecting secondary health and social care. Previous failings in safeguarding show the dangers of a disconnected system and it is critical that the new commissioning arrangements should encourage integration.</p> <p>There has been a fourfold increase in young patients on Home Parenteral Nutrition (PN) since 1993 with a mean of 13.7 children per million.<cross-ref type="bib" refid="R2">2</cross-ref> Young mothers are over-represented since teenage...]]></description>
<dc:creator><![CDATA[Protheroe, S., Debelle, G. G., Holden, C., Powell, J.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-303859</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-303859</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Health and social care: will they work together for children now?]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Editorial</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>481</prism:startingPage>
<prism:endingPage>482</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/483?rss=1">
<title><![CDATA[Protecting children and young people]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/483?rss=1</link>
<description><![CDATA[ <p>On 3 September 2012, the General Medical Council (GMC) guidance &lsquo;Protecting children and young people: the responsibility of all doctors&rsquo;<cross-ref type="bib" refid="R1">1</cross-ref> came into effect. This guidance from the GMC should be welcomed and should command support from all doctors and other health professionals.</p> <p>The circumstances that led to the development of this guidance came about from the GMC's handling of a fitness to practice hearing relating to Professor Southall in 2010. As Mr Niall Dickson, Chief Executive of the GMC, wrote in May 2010<cross-ref type="bib" refid="R2">2</cross-ref><qd><p>...there is no doubt that this case has caused considerable concern within the paediatric community. This is vital and difficult work and nothing should deter professionals from undertaking it, to protect vulnerable children across the UK.</p> </qd><qd> <p>Accordingly, we will convene an expert group to review the guidance for paediatricians involved in child protection to ensure we can provide clarity and reassurance about...]]></description>
<dc:creator><![CDATA[Roe, M. F. E.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303347</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-303347</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Child abuse, Child health, Abuse (child, partner, elder)]]></dc:subject>
<dc:title><![CDATA[Protecting children and young people]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Leading article</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>483</prism:startingPage>
<prism:endingPage>484</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/485?rss=1">
<title><![CDATA[Contemporary hazards in the home: keeping children safe from thermal injuries]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/485?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To explore the knowledge and reported thermal injury prevention practices among parents of children aged 0&ndash;4&nbsp;years in disadvantaged areas.</p>
</sec>
<sec><st>Methods</st>
<p>Parents of pre-school children in Children's Centres in four study areas in England (Nottingham, Newcastle, Norwich and Bristol) were interviewed using a structured schedule. Interviews covered smoke alarms, bedtime routines, fire escape plans, other thermal prevention practices and parental knowledge of first aid.</p>
</sec>
<sec><st>Results</st>
<p>Of the 200 respondents, most reported ownership of at least one smoke alarm (n=191, 96%), of which 95% were working. Half reported a fire prevention bedtime routine (n=105, 53%) or fire escape plan (n=81, 42%). Most parents had matches or lighters in the home (n=159, 80%), some stored where children under 5&nbsp;years of age could reach them (n=30, 19%). There was a high prevalence of irons (n=188, 94%) and hair straighteners (n=140, 70%). A third of both devices were used daily. Just 17 (12%) parents reported leaving hair straighteners, when hot but not in use, in a heatproof bag. Knowledge of correct initial first aid for a small burn was good (n=165, 83%), but parents reported other potentially harmful actions, for example, applying ointment (n=44, 22%).</p>
</sec>
<sec><st>Conclusions</st>
<p>Most families report at least one working smoke alarm, but many do not have fire escape plans or fire prevention bedtime routines. A number of reported practices could compromise child safety, such as storage of matches or lighters and leaving hair straighteners to cool unprotected. Reappraisal of health promotion messages, in light of new household consumables, is necessary.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Deave, T., Goodenough, T., Stewart, J., Towner, E., Majsak-Newman, G., Hawkins, A., Coupland, C., Kendrick, D.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302901</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-302901</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Child health, Health promotion]]></dc:subject>
<dc:title><![CDATA[Contemporary hazards in the home: keeping children safe from thermal injuries]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Original article</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>485</prism:startingPage>
<prism:endingPage>489</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/490?rss=1">
<title><![CDATA[Genetic testing in children with surfactant dysfunction]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/490?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To present the UK experience in genetic diagnoses of surfactant protein dysfunction disorders and develop a referral algorithm for neonates and children with persistent respiratory problems.</p>
</sec>
<sec><st>Materials and methods</st>
<p>Between 2006 and 2011, 427 cases were referred for surfactant mutation analyses to the North East Thames Regional Molecular Genetics Laboratory at Great Ormond Street Hospital, London. The results were reviewed and referring physicians of mutation positive cases contacted to complete a questionnaire providing clinical, radiological, histological and outcome information.</p>
</sec>
<sec><st>Results</st>
<p>25 new cases were found to have genetic mutations for surfactant dysfunction disorders (7.5%), with six resulting in surfactant protein B dysfunction, seven surfactant protein C dysfunction and 12 ATP-binding cassette subfamily A member 3 (ABCA3) dysfunction. The referrals were from 15 different paediatric centres. In addition, three affected surfactant protein B (SFTPB) cases were prenatal diagnoses, following the birth of previously affected children. The majority of the confirmed cases (23 of 25) were born after 37&nbsp;weeks gestation. All children with SFTPB dysfunction and the majority of ABCA3 patients presented with respiratory distress at birth. All SFTPB cases died from intractable respiratory failure. The outcome for ABCA3 mutations was variable with seven survivors. The clinical and radiological presentation of surfactant protein C (SFTPC) patients suggested mainly interstitial lung process with the majority surviving on medication.</p>
</sec>
<sec><st>Conclusions</st>
<p>Surfactant mutation analysis is now well established in the UK and allows better genetic diagnosis and counselling. The rarity of the condition makes it difficult to develop a validated algorithm for genetic evaluation with a need for international networking. Referrals need to be rationalised for the service to be time and cost effective.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Turcu, S., Ashton, E., Jenkins, L., Gupta, A., Mok, Q.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303166</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-303166</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Molecular genetics, Pregnancy, Reproductive medicine]]></dc:subject>
<dc:title><![CDATA[Genetic testing in children with surfactant dysfunction]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Original article</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>490</prism:startingPage>
<prism:endingPage>495</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/495?rss=1">
<title><![CDATA[Spontaneous pneumothoraces in hereditary multiple exostoses]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/495?rss=1</link>
<description><![CDATA[ <p>A 12-year-old boy, with a prior diagnosis of hereditary multiple exostoses, presented with sudden onset shortness of breath and chest pain. Physical examination and chest x-ray (CXR) revealed a large left tension pneumothorax (figures 1 and 2). A chest drain was inserted and follow-up CXR showed complete resolution, allowing discharge 4&nbsp;days later. The presence of multiple rib exostoses on CXR raised the possibility of pneumothorax occurring secondary to direct trauma from one such lesion. CT chest confirmed multiple bony exostoses and identified a causative lesion arising from the anterior left fourth rib. The patient returned 6&nbsp;months later, with an identical presentation, requiring similar management for, this time a right-sided pneumothorax. Thoracoscopy was performed 2&nbsp;months later, where the patient underwent excision of the most prominent exostoses bilaterally (figure 3). No further difficulties have been noted in this patient.</p> <p>To our knowledge this is the fist report of a child with...]]></description>
<dc:creator><![CDATA[Chawla, J. K., Jackson, M., Munro, F. D.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303289</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-303289</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Spontaneous pneumothoraces in hereditary multiple exostoses]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Miscellanea</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>495</prism:startingPage>
<prism:endingPage>496</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/497?rss=1">
<title><![CDATA[Neurodevelopment outcome of newborns with cerebral subependymal pseudocysts at 18 and 46 months: a prospective study]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/497?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Subependymal pseudocysts (SEPC) are cerebral periventricular cysts located on the floor of the lateral ventricle and result from regression of the germinal matrix. They are increasingly diagnosed on neonatal cranial ultrasound. While associated pathologies are reported, information about long-term prognosis is missing, and we aimed to investigate long-term follow-up of these patients.</p>
</sec>
<sec><st>Study design</st>
<p>Newborns diagnosed with SEPC were enrolled for follow-up. Neurodevelopment outcome was assessed at 6, 18 and 46&nbsp;months of age.</p>
</sec>
<sec><st>Results</st>
<p>74 newborns were recruited: we found a high rate of antenatal events (63%), premature infants (66% &lt;37&nbsp;weeks, 31% &lt;32&nbsp;weeks) and twins (30%). MRI was performed in 31 patients, and cystic periventricular leukomalacia (c-PVL) was primarily falsely diagnosed in 9 of them. Underlying disease was diagnosed in 17 patients, 8 with congenital cytomegalovirus (CMV) infection, 5 with genetic and 4 with metabolic disease. Neurological examination (NE) at birth was normal for patients with SEPCs and no underlying disease, except one. Mean Developmental Quotient and IQ of these patients was 98.2 (&plusmn;9.6SD; range 77&ndash;121), 94.6 (&plusmn;14.2SD; 71&ndash;120) and 99.6 (&plusmn;12.3SD; 76&ndash;120) at 6, 18 and 46&nbsp;months of age, respectively, with no differences between the subtypes of SEPC. A subset analysis showed no outcome differences between preterm infants with or without SEPC, or between preterm of &lt;32 GA and &ge;32 GA.</p>
</sec>
<sec><st>Conclusions</st>
<p>Neurodevelopment of newborns with SEPC was normal when no underlying disease was present. This study suggests that if NE is normal at birth and congenital CMV infection can be excluded, then no further investigations are needed. Moreover, it is crucial to differentiate SEPC from c-PVL which carries a poor prognosis.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Cevey-Macherel, M., Forcada Guex, M., Bickle Graz, M., Truttmann, A. C.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303223</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-303223</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Oncology, Child health, Infant health, Neonatal health, Radiology, Clinical diagnostic tests, Radiology (diagnostics), Metabolic disorders]]></dc:subject>
<dc:title><![CDATA[Neurodevelopment outcome of newborns with cerebral subependymal pseudocysts at 18 and 46 months: a prospective study]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Original article</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>497</prism:startingPage>
<prism:endingPage>502</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/503?rss=1">
<title><![CDATA[Rational prescribing in paediatrics in a resource-limited setting]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/503?rss=1</link>
<description><![CDATA[
<sec><st>Introduction</st>
<p>There is evidence of inappropriate medication use, causing unnecessary costs for health systems, particularly those with limited resources. Overprescription is commonly reported and can lead to antibiotic resistance. Prescribing patterns differ between countries; little is known about paediatric prescribing practices in Africa.</p>
</sec>
<sec><st>Objectives</st>
<p>To investigate prescribing practices in children in The Gambia, West Africa.</p>
</sec>
<sec><st>Method</st>
<p>A retrospective survey of prescribing practices in children under 5&nbsp;years of age based on WHO protocol DAP/93.1 was conducted. Twenty government-run health centres across all six regions in The Gambia were assessed. The first 10 encounters each month in 2010 were recorded. For each encounter, patient demographics, diagnoses and medications were recorded as per protocol.</p>
</sec>
<sec><st>Results</st>
<p>Two thousand and four hundred patient encounters were included. The mean number of medications per encounter was 2.2 (median 2.0, IQR 2.0&ndash;3.0). Across different geographical regions within The Gambia antibiotics were prescribed in 63.4% (IQR 62.8&ndash;65.8%) and micronutrients in 21.7% (IQR 15.3&ndash;27.1%) of patient encounters. There was evidence of high antibiotic prescription in children with cough and coryzal symptoms (54.5%; IQR 35.8&ndash;59.0%) and simple diarrhoea without dehydration (44.8%; IQR 36.7&ndash;61.3%). 74.8% (IQR 71.8&ndash;76.1%) of medications were prescribed generically.</p>
</sec>
<sec><st>Conclusions</st>
<p>The study showed an overprescription of antibiotics and substantial usage of micronutrients despite a lack of international evidence-based guidelines. Cost-effective interventions to improve prescribing practices are called for and more studies with a focus on rational prescribing in paediatrics in low-income settings are urgently required to fill the gap in current knowledge.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Risk, R., Naismith, H., Burnett, A., Moore, S. E., Cham, M., Unger, S.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302987</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-302987</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Diarrhoea, Drugs: infectious diseases, Child health, Guidelines]]></dc:subject>
<dc:title><![CDATA[Rational prescribing in paediatrics in a resource-limited setting]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Original article</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>503</prism:startingPage>
<prism:endingPage>509</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/510?rss=1">
<title><![CDATA[Environmental tobacco smoke and asthma exacerbations and severity: the difference between measured and reported exposure]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/510?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To assess the impact of measured versus reported environmental tobacco smoke (ETS) exposure on asthma severity and exacerbations in an urban paediatric population.</p>
</sec>
<sec><st>Design</st>
<p>We analysed cross-sectional data from the Chicago Initiative to Raise Asthma Health Equity study that followed a cohort of 561 children aged 8&ndash;14 with physician-diagnosed asthma between 2003 and 2005. Participant sociodemographic data and asthma symptoms were gathered by parental survey; exposures to ETS were determined by salivary cotinine levels and parent report. Multivariable negative binomial and ordered logistic regressions were used to assess associations between ETS and asthma outcomes.</p>
</sec>
<sec><st>Results</st>
<p>Among 466 children included in our analysis, 58% had moderate or severe persistent asthma; 32% had &gt;2 exacerbations requiring a hospitalisation or an emergency room visit or same day care in the previous year. Half of caregivers reported that at least one household member smoked. In multivariable analyses, salivary cotinine was significantly associated with frequently reported exacerbations in the previous year (adjusted incidence rate ratio=1.39, 95% CI 1.09 to 1.79), but not significantly associated with asthma severity. Reported household smoking was not significantly associated with either asthma severity or frequency of exacerbations.</p>
</sec>
<sec><st>Conclusions</st>
<p>Salivary cotinine was more predictive of asthma exacerbation frequency but caregiver- reported household smoking was not. Use of a nicotine biomarker may be important in both the clinical and research settings to accurately identify an important risk factor for asthma exacerbations.</p>
</sec>
]]></description>
<dc:creator><![CDATA[McCarville, M., Sohn, M.-W., Oh, E., Weiss, K., Gupta, R.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303109</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-303109</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Oncology, Smoking and tobacco, Immunology (including allergy), Child health, Asthma, Health education, Health promotion, Smoking]]></dc:subject>
<dc:title><![CDATA[Environmental tobacco smoke and asthma exacerbations and severity: the difference between measured and reported exposure]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Original article</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>510</prism:startingPage>
<prism:endingPage>514</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/514?rss=1">
<title><![CDATA[Use of an artificial pancreas at diabetes camps]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/514?rss=1</link>
<description><![CDATA[ <sec> <p>Attempts to improve blood glucose control in type 1 diabetes have led to the use of technology such as insulin pumps and glucose sensors, or both (sensor augmented pump) but they have not eliminated the risk of nocturnal hypoglycaemia. It has been estimated that three quarters of hypoglycaemic seizures in children occur during the night. Fully automated artificial pancreas systems use computer controlled algorithms to link glucose sensors with insulin pumps to control insulin delivery. Such devices have improved blood glucose control in hospital trials and have reduced the risk of nocturnal hypoglycaemia. New researchers in Israel, Slovenia and Germany (Moshe Phillips and colleagues. <I>New England Journal of Medicine</I> 2013;<b>368</b>:824&ndash;33) have used the artificial pancreas system at a youth diabetes camp in each of these countries.</p> <p>The study included a total of 56 patients aged 10&ndash;18 years who had had type 1 diabetes for at least a year,...]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-304450</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-304450</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Use of an artificial pancreas at diabetes camps]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Miscellanea</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>514</prism:startingPage>
<prism:endingPage>514</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/515?rss=1">
<title><![CDATA[School-based physical activity programme in preadolescent girls (9-11 years): a feasibility trial in Karachi, Pakistan]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/515?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Effective strategies to combat childhood obesity are challenging, especially among South Asian girls. We conducted a pilot cluster trial of a school-based physical activity programme among preadolescent girls to determine the feasibility (recruitment, retention and implementation) of the programme and influence on blood pressure (BP) and body mass index (BMI).</p>
</sec>
<sec><st>Methods</st>
<p>This two-arm parallel cluster intervention trial was conducted in four similar all-girls public sector schools in Karachi over a 20-week period. All girls aged 9&ndash;11&nbsp;years were included. Intervention was a physical activity programme of 30&nbsp;min duration four times a week. Primary outcome was to assess the feasibility of the physical activity programme defined as recruitment and retention &gt;70% and treatment fidelity of &gt;80% of physical activity programme. Secondary outcomes were changes in systolic BP (SBP), diastolic BP (DBP) and BMI from baseline to follow-up.</p>
</sec>
<sec><st>Results</st>
<p>A total of 360 participants were invited to participate, 280 girls met eligibility criteria, and were recruited; 131 (77%) in the intervention group and 146 (87%) in control group. At follow-up, the overall retention of participants was 222 (79.2%); 105 (80.1%) in the intervention group and 117 (78.5%) in the control group. The difference in mean change from baseline to follow-up in SBP, DBP and BMI score was 1.9&nbsp;mm&nbsp;Hg, 0.7&nbsp;mm&nbsp;Hg and 0.55&nbsp;kg/m<sup>2</sup> between intervention and control arms, respectively.</p>
</sec>
<sec><st>Conclusions</st>
<p>A school-based physical activity programme in a public sector girls school of urban Pakistan is feasible. There was a favourable trend in BP and BMI at follow-up. (Clinical trial ID NCT 00533819).</p>
</sec>
]]></description>
<dc:creator><![CDATA[Almas, A., Islam, M., Jafar, T. H.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303242</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-303242</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Hypertension, Obesity (nutrition), Child health, Health education, Obesity (public health), Health promotion]]></dc:subject>
<dc:title><![CDATA[School-based physical activity programme in preadolescent girls (9-11 years): a feasibility trial in Karachi, Pakistan]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Original article</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>515</prism:startingPage>
<prism:endingPage>519</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/520?rss=1">
<title><![CDATA[Terra Firma-Forme Dermatosis: it's easy when you know it]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/520?rss=1</link>
<description><![CDATA[ <p>A 10-year-old boy presented to the outpatient department with pigmented plaques behind his ears and on his right forearm (see <cross-ref type="fig" refid="ARCHDISCHILD2012303499F1">figures 1</cross-ref> and <cross-ref type="fig" refid="ARCHDISCHILD2012303499F2">2</cross-ref>). He was asymptomatic and his hygiene was very good. Dermatology review of the photographs suggested a diagnosis of Terra Firma-Forme Dermatosis and a recommendation to use alcohol wipes was made. On contacting the family his mother reported that the rash had resolved following the application of almond oil thereby confirming the diagnosis.</p> <p>Terra Firma-Forme Dermatosis is still sometimes referred to as <I>Duncan's Dirty Dermatosis</I> following the initial publication by Duncan <I>et al</I>.<cross-ref type="bib" refid="R1">1</cross-ref> It is characterised by idiopathic hyperkeratosis that appears as dirt-like discolouration which cannot be removed by washing with soap and water.<cross-ref type="bib" refid="R2">2</cross-ref></p> <p>The condition is more common in children than adults and is most commonly found on neck, face and ankles.<cross-ref type="bib" refid="R3">3</cross-ref> When suspected early,...]]></description>
<dc:creator><![CDATA[Ratcliffe, A., Williamson, D., Hesseling, M.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303499</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-303499</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Terra Firma-Forme Dermatosis: it's easy when you know it]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Miscellanea</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>520</prism:startingPage>
<prism:endingPage>520</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/521?rss=1">
<title><![CDATA[Management of urinary tract infection in a tertiary children's hospital before and after publication of the NICE guidelines]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/521?rss=1</link>
<description><![CDATA[
<sec><st>Introduction</st>
<p>The UK National Institute for Health and Clinical Excellence (NICE) introduced guidelines for the diagnosis, treatment and management of urinary tract infection (UTI) in children and adolescents in August 2007.</p>
</sec>
<sec><st>Aim</st>
<p>The primary aim was to determine whether publication of NICE guidelines was associated with a change in the use of diagnostic imaging investigations in patients with a documented first UTI in a tertiary children's hospital. Secondary aims were to describe the epidemiology, microbiology, prescription of prophylactic antibiotics and follow-up for these children, and the incidence of structural renal tract abnormalities, vesicoureteric reflux and renal uptake defects identified.</p>
</sec>
<sec><st>Methods</st>
<p>Retrospective review of the case notes of patients presenting to Princess Margaret Hospital, Perth, Western Australia with a first UTI over a 4-year period (August 2005&ndash;2009). Details of demographics, radiological investigations, microbiology and follow-up were obtained. Data for subjects presenting before and after 31 August 2007 were compared.</p>
</sec>
<sec><st>Results</st>
<p>Data from 659 subjects, median age 6 (range 0&ndash;186) months were analysed. Compared with the pre-NICE period, there was no change in the proportion of patients undergoing renal USS in the 2&nbsp;years following publication of the guidelines. There was a decrease in the proportion undergoing MCUG (p&lt;0.0001) and receiving antibiotic prophylaxis (p&lt;0.0001) and an increase in the proportion undergoing DMSA (p&lt;0.001).</p>
</sec>
<sec><st>Conclusions</st>
<p>Practice changed following publication of the NICE guidelines. While the reduction in MCUG requests and prescription of antibiotic prophylaxis is in line with NICE guidelines, the increase in DMSA requests is contrary to the recommendations.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Judkins, A., Pascoe, E., Payne, D., Keil]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303032</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-303032</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Urology, Drugs: infectious diseases, Urinary tract infections, Child health, Urinary tract infections]]></dc:subject>
<dc:title><![CDATA[Management of urinary tract infection in a tertiary children's hospital before and after publication of the NICE guidelines]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Original article</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>521</prism:startingPage>
<prism:endingPage>525</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/526?rss=1">
<title><![CDATA[The association between caesarean section and childhood obesity revisited: a cohort study]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/526?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>The mode of delivery has recently gained attention as another potential perinatal risk factor for childhood obesity but results are conflicting.</p>
</sec>
<sec><st>Objective</st>
<p>To examine whether caesarean section is independently associated with childhood obesity after adjusting for a broad range of confounding factors.</p>
</sec>
<sec><st>Methods</st>
<p>The current study used a population-based survey in Grade 5 students linked to a provincial perinatal registry in the Canadian province of Nova Scotia. Associations between caesarean section and childhood overweight and obesity at age 10/11&nbsp;years were examined using multiple logistic regression.</p>
</sec>
<sec><st>Results</st>
<p>Of the 4298 students who participated in the 2003 Children's Lifestyle and School Performance Study (response rate 51.1%), 3426 (80%) could be linked with information in the Atlee Perinatal Database, and 2988 mother-child pairs (70%) had complete information on the exposure and outcome. Compared to vaginal delivery, caesarean section was associated with offspring obesity (OR) 1.49, 95% CI 1.10 to 2.00) in the univariate analysis. After adding maternal prepregnancy weight to the multiple regression model, the OR for obesity dropped from 1.48 to 1.20 (95% CI 0.87 to 1.65). When caesarean section with and without labour were considered separately, we found no statistically significant associations relative to the vaginal delivery group (OR 1.24, 95% CI 0.84 to 1.82 and OR 1.03, 95% CI 0.58 to 1.84).</p>
</sec>
<sec><st>Conclusion</st>
<p>Our results do not support a causal association between caesarean section and childhood obesity. Maternal prepregnancy weight was an important confounder in the association between caesarean delivery and childhood obesity and needs to be considered in future studies.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Flemming, K., Woolcott, C. G., Allen, A. C., Veugelers, P. J., Kuhle, S.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303459</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-303459</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Obesity (nutrition), Child health, Health education, Obesity (public health), Health promotion]]></dc:subject>
<dc:title><![CDATA[The association between caesarean section and childhood obesity revisited: a cohort study]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Original article</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>526</prism:startingPage>
<prism:endingPage>532</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/533?rss=1">
<title><![CDATA[Morbidity among child travellers with sickle-cell disease visiting tropical areas: an observational study in a French tertiary care centre]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/533?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To examine morbidity among children with sickle-cell disease (SCD) during and after travel to a tropical area.</p>
</sec>
<sec><st>Design</st>
<p>Observational study.</p>
</sec>
<sec><st>Setting</st>
<p>Tertiary care children; Robert Debr&eacute; Hospital, Paris, France.</p>
</sec>
<sec><st>Population</st>
<p>Children with SCD younger than 18&nbsp;years old and managed in the SCD referral centre at the Robert Debr&eacute; Hospital who travelled to a tropical or subtropical area between 1 June 2009 and 31 December 2009.</p>
</sec>
<sec><st>Main outcome</st>
<p>To assess morbidity, we used the number of clinical events requiring medical consultation during the trip as the primary outcome and the number of hospitalisations required after returning as the secondary outcome.</p>
</sec>
<sec><st>Results</st>
<p>Thirty-nine children were included. The median age was 7.8&nbsp;years (4.3&ndash;11.7 years). All of the children and their parents attended a pretravel visit focusing on the prevention of travel-related diseases. Twelve children (30%) consulted a physician while they were abroad. Thirteen children (33%) were hospitalised, and 23 children (59%) consulted a physician while they were abroad or within 3&nbsp;months after returning to France. Considering the 3&nbsp;months before and after travel, the number of children hospitalised after travel (n=12, 30.7%) was significantly higher than the number hospitalised before (n=4, 10.2%; p=0.01). One child was hospitalised for multifocal osteoarthritis as a complication of <I>Salmonella enterica</I> septicaemia of gastrointestinal origin.</p>
</sec>
<sec><st>Conclusions</st>
<p>Travels to tropical areas are associated with high morbidity in children with SCD. Salmonella infection is a particularly significant threat, and empirical antibiotic therapy should be prescribed routinely for traveller's diarrhoea in this population.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Sommet, J., Missud, F., Holvoet, L., Ithier, G., Lorrot, M., Benkerrou, M., Faye, A.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302500</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-302500</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Oncology, Diarrhoea, Epidemiologic studies, Drugs: infectious diseases, Child health, Rheumatology]]></dc:subject>
<dc:title><![CDATA[Morbidity among child travellers with sickle-cell disease visiting tropical areas: an observational study in a French tertiary care centre]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Original article</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>533</prism:startingPage>
<prism:endingPage>536</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/537?rss=1">
<title><![CDATA[Acute abdomen due to splenic torsion]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/537?rss=1</link>
<description><![CDATA[ <p>A 14-year-old girl presented to our department for having collapsed after an acute episode of epigastric pain and vomiting. Past medical history was uneventful; in particular no previous abdominal complaints were mentioned. Physical examination showed a palpable tenderness in the epigastric region. Initially, gastroenteritis was suspected. Abdominal ultrasound revealed massive splenomegaly and in Doppler ultrasound splenic vein thrombosis was suspected. CT with CT angiography showed an enlarged, non-enhancing spleen with characteristic signs of splenic torsion (whirl sign, <cross-ref type="fig" refid="ARCHDISCHILD2012303481F1">figure 1</cross-ref>). Emergency laparotomy revealed haemorrhagic infarction of the spleen due to clockwise torsion of the vascular pedicle of 720&deg; (<cross-ref type="fig" refid="ARCHDISCHILD2012303481F2">figure 2</cross-ref>). The spleen had no fixation to the diaphragm and the posterior abdominal wall. Thrombosis of the hilar vein and artery was confirmed and splenectomy was performed. The girl showed uneventful recovery.</p> <p>The spleen is usually fixed in a retroperitoneal position within the abdominal cavity by the...]]></description>
<dc:creator><![CDATA[Kargl, S., Sekyra, P., Pumberger, W.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303481</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-303481</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Acute abdomen due to splenic torsion]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Miscellanea</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>537</prism:startingPage>
<prism:endingPage>537</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/538?rss=1">
<title><![CDATA[How does obstructive sleep apnoea evolve in syndromic craniosynostosis? A prospective cohort study]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/538?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To describe the course of obstructive sleep apnoea syndrome (OSAS) in children with syndromic craniosynostosis.</p>
</sec>
<sec><st>Design</st>
<p>Prospective cohort study.</p>
</sec>
<sec><st>Setting</st>
<p>Dutch Craniofacial Centre from January 2007 to January 2012.</p>
</sec>
<sec><st>Patients</st>
<p>A total of 97 children with syndromic craniosynostosis underwent level III sleep study. Patients generally undergo cranial vault remodelling during their first year of life, but OSAS treatment only on indication.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Obstructive apnoea-hypopnoea index, the central apnoea index and haemoglobin oxygenation-desaturation index derived from consecutive sleep studies.</p>
</sec>
<sec><st>Results</st>
<p>The overall prevalence of OSAS in syndromic craniosynostosis was 68% as defined by level III sleep study. Twenty-three patients were treated for OSAS. Longitudinal profiles were computed for 80 untreated patients using 241 sleep studies. A mixed effects model showed higher values for the patients with midface hypoplasia as compared to those without midface hypoplasia (Omnibus likelihood ratio test=7.9). In paired measurements, the obstructive apnoea-hypopnoea index (Z=&ndash;3.4) significantly decreased over time, especially in the first years of life (Z=&ndash;3.3), but not in patients with midface hypoplasia (Z=&ndash;1.5). No patient developed severe OSAS during follow-up if it was not yet diagnosed during the first sleep study.</p>
</sec>
<sec><st>Conclusions</st>
<p>OSAS is highly prevalent in syndromic craniosynostosis. There is some natural improvement, mainly during the first 3&nbsp;years of life and least in children with Apert or Crouzon/Pfeiffer syndrome. In the absence of other co-morbid risk factors, it is highly unlikely that if severe OSAS is not present early in life it will develop during childhood. Ongoing clinical surveillance is of great importance and continuous monitoring for the development of other co-morbid risk factors for OSAS should be warranted.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Driessen, C., Joosten, K. F. M., Bannink, N., Bredero-Boelhouwer, H. H., Hoeve, H. L. J., Wolvius, E. B., Rizopoulos, D., Mathijssen, I. M. J.]]></dc:creator>
<dc:date>2013-06-11T04:29:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302745</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-302745</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Rheumatology]]></dc:subject>
<dc:title><![CDATA[How does obstructive sleep apnoea evolve in syndromic craniosynostosis? A prospective cohort study]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Original article</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>538</prism:startingPage>
<prism:endingPage>543</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/544?rss=1">
<title><![CDATA[Giant Hogweed burns]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/544?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>A 13-year-old boy presented to A&amp;E with an erythematous rash on his lower legs, arms and torso after swimming in a local river the previous day. On initial examination, he appeared well and afebrile with several irregularly shaped erythematous lesions that were tender and warm to touch (<cross-ref type="fig" refid="ARCHDISCHILD2012303229F1">figure 1</cross-ref>A,B). Inflammatory and infection markers were normal but intravenous flucloxacillin was commenced &nbsp;for possible cellulitis.</p> <p>The following day the lesions progressed into a distressing painful blistering rash. The diagnosis remained unclear until the boy's father visited and proclaimed the lesions Giant Hogweed burns. Diagnosis was confirmed by internet searches and collaboration with dermatology.</p> <p>Treatment of Hogweed-induced phytophotodermatitis follows that for chemical burns. Large bullous lesions were de-roofed and potassium permanganate impregnated dressings used for their bactericidal and astringent properties. The addition of paraffin gauze dressings showed an immediate improvement in pain and prevented further damage from ultraviolet...]]></description>
<dc:creator><![CDATA[Probert, S. M., Lacey, J., Gautam, S.]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303229</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-303229</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Giant Hogweed burns]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Miscellanea</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>544</prism:startingPage>
<prism:endingPage>544</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/545?rss=1">
<title><![CDATA[Utility of red cell distribution width in screening for iron deficiency]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/545?rss=1</link>
<description><![CDATA[
<sec><st>Aims</st>
<p>To assess the sensitivity of an adult-derived red cell distribution width (RDW) reference limit in the detection of iron deficiency in young children.</p>
</sec>
<sec><st>Methods</st>
<p>Haematological analysis performed on a cohort of 13-month-old healthy term infants of North European ancestry.</p>
</sec>
<sec><st>Results</st>
<p>21/98 infants were iron-deficient (&gt;2.5% hypochromic red cells). Of the remaining 77, 35 with RDW &gt;13.9% also had evidence of incipient iron deficiency on the basis of significantly lower haemoglobin (11.5 vs 11.8&nbsp;g/dl, p=0.046), mean cell volume (75.6 vs 77.8&nbsp;fl, p=0.002) and mean cell haemoglobin (25.4 vs 26.2&nbsp;pg, p=0.002) values and higher zinc protoporphyrin (55 vs 44&nbsp;&mu;mol/molhaem, p&lt;0.001) values than those of the 42 with RDW &le;13.9%.</p>
</sec>
<sec><st>Conclusions</st>
<p>An adult-derived RDW reference limit has utility in screening for iron deficiency at the age of 13&nbsp;months. The incidence of non-anaemic iron deficiency in this group was 52.8%.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Hinchliffe, R. F., Bellamy, G. J., Finn, A., Bell, F., Vora, A. J., Lennard, L.]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303160</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-303160</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Malnutrition, Screening (epidemiology), Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Utility of red cell distribution width in screening for iron deficiency]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Short research report</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>545</prism:startingPage>
<prism:endingPage>547</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/548?rss=1">
<title><![CDATA[Sleep disturbance in childhood epilepsy: clinical implications, assessment and treatment]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/548?rss=1</link>
<description><![CDATA[
<p>The ways in which sleep can affect epilepsy, and epilepsy can influence sleep and wakefulness, are described. Different forms of sleep disturbance have been reported in patients with epilepsy, depending on the type of seizure disorder. Confusions between epilepsy and non-epileptic parasomnias can be a particular diagnostic problem but they can be avoided. Untreated sleep disturbance is likely to have harmful psychological, physical and family effects. Screening for sleep disturbance should be routine, and leading, if indicated, to precise diagnosis of the underlying sleep disorder on which choice of advice and treatment depends.</p>
]]></description>
<dc:creator><![CDATA[Stores, G.]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-303825</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-303825</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Epilepsy and seizures, Sleep disorders (neurology), Child health, Sleep disorders, Sleep disorders (respiratory medicine), Screening (epidemiology), Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Sleep disturbance in childhood epilepsy: clinical implications, assessment and treatment]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Review</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>548</prism:startingPage>
<prism:endingPage>551</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/552?rss=1">
<title><![CDATA[Strategies to control pertussis in infants]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/552?rss=1</link>
<description><![CDATA[
<p>The UK is currently in the midst of a large outbreak of pertussis, with the highest morbidity and mortality occurring in young unimmunised infants. This review considers the potential strategies to optimise control of pertussis in infants, including vaccination of (1) adolescents, (2) close household contacts of newborn infants (cocooning), (3) newborn infants and (4) pregnant women. The paper discusses the evidence base for each of these strategies and considers the rationale for the recent introduction of a temporary vaccination programme for pregnant women in the UK in response to the ongoing outbreak.</p>
]]></description>
<dc:creator><![CDATA[Amirthalingam, G.]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302968</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-302968</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Editor's choice, Immunology (including allergy), Drugs: infectious diseases, TB and other respiratory infections, Vaccination / immunisation, Pregnancy, Reproductive medicine, Adolescent health, Child health]]></dc:subject>
<dc:title><![CDATA[Strategies to control pertussis in infants]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Review</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>552</prism:startingPage>
<prism:endingPage>555</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/556?rss=1">
<title><![CDATA[Recurrent life-threatening sepsis in intestinal failure: transplantation or foster care?]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/556?rss=1</link>
<description><![CDATA[
<p>Parenteral nutrition has transformed the outlook for patients with intestinal failure, but is associated with serious long-term complications, including catheter-related blood stream infection, liver disease and loss of venous access. Risks can be significantly reduced by strict adherence to management regimens, such as catheter-care protocols, but intestinal transplantation is indicated when complications threaten survival. The responsibility of home parenteral nutrition as an alternative to long-term hospitalisation is welcomed by many parents, but represents a huge burden of care that sometimes proves beyond their capacity. We report two children with recurrent life-threatening central venous catheter infections who were removed from the intestinal transplant list following virtual cessation of infective episodes after going into foster care. These cases raise important issues about the level of family support offered, the role of non-compliance with treatment routines in relation to risk of complications, and how this should be assessed and monitored.</p>
]]></description>
<dc:creator><![CDATA[Zamvar, V., Lazonby, G., Puntis, J. W. L.]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302317</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-302317</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Liver disease, Open access, Childhood nutrition, Childhood nutrition (paediatrics), Child health]]></dc:subject>
<dc:title><![CDATA[Recurrent life-threatening sepsis in intestinal failure: transplantation or foster care?]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Case report</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>556</prism:startingPage>
<prism:endingPage>557</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/558?rss=1">
<title><![CDATA[Should critically ill children with acute respiratory failure be treated with surfactant?]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/558?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Scenario</st> <p>A 9-year-old child with relapsed acute lymphoblastic leukaemia postbone marrow transplant was admitted to the children's intensive care unit (ICU) for non-neutropenic fever with worsening respiratory distress that required mechanical ventilation. Despite broad-spectrum antimicrobials, serial chest radiographs showed worsening bilateral infiltrates and increasing mechanical ventilatory requirements. As the registrar in the unit, you wondered if intratracheal surfactant would be beneficial in treating this child with acute respiratory failure.</p> </sec> <sec id="s2"><st>Structured clinical question</st> <p>In critically ill children with acute respiratory failure (patient), does treatment with surfactant (intervention) improve gaseous exchange and shorten duration of mechanical ventilation and length of ICU stay (outcomes)?</p> </sec> <sec id="s3"><st>Search strategy and outcome</st> <p>Secondary source&mdash;Cochrane Database of Systematic Review, BestBETs</p> <p>Primary source&mdash;PubMed, CINAHL, Web of Science</p> <p>Search terms were (&lsquo;children&rsquo;) AND (&lsquo;surfactant&rsquo;) AND (&lsquo;acute respiratory distress syndrome&rsquo; OR &lsquo;adult respiratory distress syndrome&rsquo; OR &lsquo;acute lung injury&rsquo; OR &lsquo;acute respiratory failure&rsquo;).</p> <sec id="s3a"><st>Search...]]></description>
<dc:creator><![CDATA[Ng, Z. M., Kavalloor, N. V., Lee, J. H.]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-303633</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-303633</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[ADC Archimedes, Oncology, Epidemiologic studies, Bronchiolitis, Pneumonia (infectious disease), TB and other respiratory infections, Child health, Radiology, Adult intensive care, Bronchitis, Mechanical ventilation, Pneumonia (respiratory medicine), Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[Should critically ill children with acute respiratory failure be treated with surfactant?]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Archimedes</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>558</prism:startingPage>
<prism:endingPage>561</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/558-a?rss=1">
<title><![CDATA[Towards evidence based medicine for paediatricians]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/558-a?rss=1</link>
<description><![CDATA[ <sec> <p></p> <p><textbox><caption><p>Thas nowt so blind as &lsquo;em that won't see</p> </caption> <p>The RAMbo acronym that Archimedes first chattered on about five years ago<cross-ref type="bib" refid="R1">1</cross-ref> relied on the key suspected elements of risk of bias&mdash;the need for randomisation, accurate ascertainment of outcomes in the groups to which people were randomised, and being careful of measurement&mdash;thinking about what was actually measured and if it was blinded, and if not blinded, objective.</p> <p>As with so many elements of evidence based medicine, the idea of checking if blinding of subjective outcomes really does make a difference has been subject to intense, methodologically robust, systematic review. A paper from the Cochrane centre<cross-ref type="bib" refid="R2">2</cross-ref> undertook a review of trials where the same outcome measurement scale had been used in situations where both blinded and unblinded observers had made assessments. They showed that, on average, the unblinded observers noted a 65% greater effect...]]></description>
<dc:creator><![CDATA[Phillips, B.]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-304248</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-304248</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[ADC Archimedes, Journalology, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[Towards evidence based medicine for paediatricians]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Archimedes</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>558</prism:startingPage>
<prism:endingPage>558</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/561?rss=1">
<title><![CDATA[Is there effective behavioural treatment for children with chronic fatigue syndrome/myalgic encephalomyelitis?]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/561?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Scenario</st> <p>A 15-year-old girl comes to your outpatient clinic with a 6-month history of fatigue, headaches, nausea and muscle pain. Clinical examination and investigations are normal and you make a diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). She is going to sit her General Certificate of Secondary Education (GCSE) examinations in 6&nbsp;months, but is currently unable to attend school full time. She and her mother ask you which behavioural treatment (they don't want medication) is the most likely to get her back to school.</p> </sec> <sec id="s2"><st>Structured clinical question</st> <p>Do teenagers with CFS/ME (P) benefit from behavioural treatments (I) compared with usual care (C) in improving school attendance and fatigue (O).<cross-ref type="tbl" refid="ARCHDISCHILD2013304307TB1"></cross-ref></p> </sec> <sec id="s3"><st>Search</st> <p>A comprehensive list of synonyms was compiled for the subjects (adolescents) and the condition (CFS). These were then combined and applied to the following databases so that all possible combinations of synonyms...]]></description>
<dc:creator><![CDATA[Smith, S. N., Crawley, E.]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-304307</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-304307</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[ADC Archimedes, Clinical trials (epidemiology), Epidemiologic studies, Drugs: CNS (not psychiatric), Headache (including migraine), Infection (neurology), Neuromuscular disease, Pain (neurology), Adolescent health, Child health, Complementary medicine, Physiotherapy, Rheumatology]]></dc:subject>
<dc:title><![CDATA[Is there effective behavioural treatment for children with chronic fatigue syndrome/myalgic encephalomyelitis?]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Archimedes</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>561</prism:startingPage>
<prism:endingPage>563</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/564?rss=1">
<title><![CDATA[A painless pigmented pinna lesion]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/564?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Case report</st> <p>A 15-year-old boy presented with a 2-month history of a painless lesion on the right earlobe and multiple neck lumps. He had emigrated from Pakistan 4&nbsp;years earlier and had received the Bacillus Calmette&ndash;Gu&eacute;rin (BCG) vaccine at birth. He denied systemic or respiratory symptoms. On examination, a 14&nbsp;mm soft painless pigmented lesion on the pinna was noted (<cross-ref type="fig" refid="ARCHDISCHILD2013303906F1">figure 1</cross-ref>). Multiple discreet lymph nodes were palpable on either side of the neck. A Mantoux test was positive but a chest x-ray was unremarkable. Excision biopsy for histology and culture from the ear and representative lymph node showed multiple caseating granulomata with acid-fast bacilli (AFB) on Ziehl&ndash;Neelsen staining. Subsequent culture grew <I>Mycobacterium tuberculosis,</I> which was treated with a 6-month course of antituberculosis treatment, to good effect.</p> </sec> <sec id="s2"><st>Discussion</st> <p>Lupus vulgaris represents the most common form of cutaneous tuberculosis in Pakistani children and primarily affects the head...]]></description>
<dc:creator><![CDATA[Bhatt, Y. M.]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-303906</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-303906</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[A painless pigmented pinna lesion]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Miscellanea</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>564</prism:startingPage>
<prism:endingPage>564</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/565?rss=1">
<title><![CDATA[Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/565?rss=1</link>
<description><![CDATA[ <p>Retinopathy of prematurity (ROP) can progress to neovascularisation (NV) and retinal detachment. Laser photocoagulation<cross-ref type="bib" refid="R1">1</cross-ref> or intravitreal bevacizumab (Avastin)<cross-ref type="bib" refid="R2">2</cross-ref> are the current interventions for severe ROP. Vascular endothelial growth factor (VEGF) plays a key role in ROP pathogenesis, being downregulated and upregulated in vaso-obliterative and vaso-proliferative phases of ROP, respectively. ROP and infantile haemangiomas share the same VEGF-mediated pathogenesis. Propranolol downregulates VEGF expression, and thus, mitigates progression of infantile haemangiomas<cross-ref type="bib" refid="R3">3</cross-ref> and NV in oxygen-induced retinopathy in animals.<cross-ref type="bib" refid="R4">4</cross-ref> We examined the safety and feasibility of propranolol for ROP.</p> <p>Twenty premature infants with ROP, born between 1 May 2010 and 31 July 2012 at 24&ndash;28 weeks&rsquo; gestation and birth weight &lt;1500 g, were randomised either to oral propranolol (propranolol+sucrose 5%; n=10) or placebo (sucrose 5%; n=10) (<cross-ref type="fig" refid="ARCHDISCHILD2013303951F1">figure 1</cross-ref>). Inclusion criterion: evidence for ROP with any of the following: (a) stage 1 (zone...]]></description>
<dc:creator><![CDATA[Makhoul, I. R., Peleg, O., Miller, B., Bar-Oz, B., Kochavi, O., Mechoulam, H., Mezer, E., Ulanovsky, I., Smolkin, T., Yahalom, C., Khoury, A., Lorber, A., Nir, A., Blazer, S.]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-303951</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-303951</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>PostScript</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>565</prism:startingPage>
<prism:endingPage>567</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/565-a?rss=1">
<title><![CDATA[Window blind cords and accidental strangulation]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/565-a?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Case report</st> <p>A 22-month-old boy was admitted to the children's ward through Accident and Emergency (A&amp;E) with accidental hanging from a window blind cord. On the day of the incident at around 18:30, the child was with his elder sister in a bedroom and his mother was in the kitchen. When his mother came back after about 4&nbsp;min of absence from the bedroom, the child was found hanging onto a pull chain of the blind cord of the window. He was not breathing and was blue. His mother immediately picked him up and laid him on the ground; after about 20&nbsp;s, he started breathing and his colour improved. When the paramedics arrived shortly after that, the child's breathing pattern had normalised. There were obvious strangulation marks on the front and side of his neck with multiple petechiae on the face. As the boy remained well overnight, he was...]]></description>
<dc:creator><![CDATA[Datta, M., Cyriac, J.]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-303963</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-303963</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Window blind cords and accidental strangulation]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>PostScript</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>565</prism:startingPage>
<prism:endingPage>565</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/567?rss=1">
<title><![CDATA[Ethical and regulatory considerations in the use of individual participant data for studies of disease prediction]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/567?rss=1</link>
<description><![CDATA[ <p>It has been suggested that individual participant data (IPD) meta-analyses of randomised controlled trials are the &lsquo;gold standard&rsquo; approach to systematic review, allowing the most robust and unbiased assessment of research evidence to provide the most accurate information regarding the efficacy of a therapy.<cross-ref type="bib" refid="R1">1</cross-ref> Such projects aim to collect raw line by line participant data from a range of relevant studies, often with updates of their outcome measures. The value of the IPD approach to review predictive studies, those assessing prognostic markers, clinical prediction rules or diagnostic tests, has also been stated.<cross-ref type="bib" refid="R2">2</cross-ref></p> <p>In forming an international collaborative to find clinical variables that predict the outcome of children and young people presenting with febrile neutropenia, we undertook an investigation into the ethical and regulatory considerations involved in sharing such information for our projects. This paper reports the outcome of our work to help inform the practice...]]></description>
<dc:creator><![CDATA[Phillips, B., Ranasinghe, N., Stewart, L. A., on behalf of the PICNICC Collaboration, Ammann, Kuehne, Niggli, Nadal, Hann, Sung, Klaassen, Alexander, Lehrnbecher, Simon, Meidema, Tissing, Sutton, Riley, Chisholm, Dommett, Castagnola, Silva, Tordecilla, Spassova, Hakim, Stryjewski, Tezcan, Kitanovski, Bauters, Laureys, Paesmann, Donnelly]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-304149</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-304149</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Ethical and regulatory considerations in the use of individual participant data for studies of disease prediction]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>PostScript</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>567</prism:startingPage>
<prism:endingPage>568</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/568?rss=1">
<title><![CDATA[The importance of currency in data trends]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/568?rss=1</link>
<description><![CDATA[ <sec> <p>The recent paper by Gill <I>et al</I><cross-ref type="bib" refid="R1">1</cross-ref> adds further weight to the belief that more can be done to prevent children with acute illnesses being admitted to hospital. They report a year-on-year rise in admissions to hospital, generally made up of young infants with short-lived episodes. This information is vital as health services, commissioners and governments must have up-to-date data on the trends in the use of the services by children and young people. However, the period examined was the first decade the 21st century and even in the last 3&nbsp;years there have been significant efforts made by acute and community services to reverse this trend.</p> <p>In our emergency department we have examined data on presentations and admissions rates in age groups from 2008 to 2012 (<cross-ref type="tbl" refid="ARCHDISCHILD2013304182TB1">table 1</cross-ref>). During that time overall attendances rose by 9.91%, our conversion rate (admissions/attendances) rose by only 0.72%,...]]></description>
<dc:creator><![CDATA[Roland, D., Shahzad, M. W., Davies, F.]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-304182</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-304182</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[The importance of currency in data trends]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>PostScript</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>568</prism:startingPage>
<prism:endingPage>569</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/7/570?rss=1">
<title><![CDATA[Highlights from the literature]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/7/570?rss=1</link>
<description><![CDATA[ <sec> <p>Up to 20% of people with tuberous sclerosis complex develop subependymal giant cell astrocytomas that are usually situated near the foramen of Monroe and commonly obstruct CSF flow, causing hydrocephalus. Operation on these tumours may be hazardous and about a third of patients has an ipsilateral recurrence or contralateral occurrence. Activation of the mammalian target of rapamycin complex 1 (mTORC1) is fundamental to tumour growth in tuberous sclerosis complex, and everolimus inhibits mTOR. A preliminary study showed that treatment with everolimus caused shrinking of subependymal giant cell astrocytomas. Now a trial in Europe, North America, and Australia (<I>Lancet</I> 2013;<b>381</b>:125&ndash;32; see also Comment, ibid:95&ndash;6) has given support to the use of everolimus for these patients. The trial included a total of 117 patients aged 0&ndash;65&nbsp;years (20 &lt;3&nbsp;years old, 101 &lt;18&nbsp;years old) with tuberous sclerosis complex and at least one new or growing subependymal giant cell astrocytoma, or associated new...]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2013-06-11T04:29:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-304449</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2013-304449</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Highlights from the literature]]></dc:title>
<prism:publicationDate>2013-07-01</prism:publicationDate>
<prism:section>Miscellanea</prism:section>
<prism:volume>98</prism:volume>
<prism:number>7</prism:number>
<prism:startingPage>570</prism:startingPage>
<prism:endingPage>570</prism:endingPage>
</item>
</rdf:RDF>